Frederick National Laboratory for Cancer Research

Our employees are passionate and hardworking professionals who genuinely care about the projects they support. Why? Because we are inspired by each other, and we help one another feel confident and cared for. If you’re looking for a rewarding career with a global impact, visit our website to learn more: https://lnkd.in/gD4CNKVw

SAVE THE DATE! Join us on February 7, 2025, for our fourth #WomenInScienceSpeak! Hosted by Woman to Woman Mentoring, Frederick National Laboratory, and Hood College, this is the perfect chance for college students and rising STEM professionals to connect and learn from incredible women in science. Expect real talk on career paths, allyship, mentorship, and tips for advancing in STEM. Don’t miss out—mark your calendar for this free hybrid event!

Project managers! Join us for the next Project Management Night Out Seminar: Walk the Talk - Agile Project Management.? ??? December 4 ? 6 pm This talk will explore various methodologies and frameworks, followed by a discussion of a hypothetical project scenario where Agile methodologies are applied to implement a complex technology project. Register now: https://lnkd.in/edZxcRN6 #ProjectManagement #Networking Hood College

“It’s a great example of how our work and unique experiences on behalf of the government serve not only the clinical trial participants around the world, but also as a?resource for our clinical research colleagues," -Shelly Simpson, director of our Clinical Monitoring Research Program. "The program demonstrates how the Frederick National Laboratory for Cancer Research deals with difficult clinical trial scenarios, and it serves as a valuable resource for clinical trial professionals," - Ethan Dmitrovsky, MD, director of FNL. Our newest educational and training resource, the FNL Global Clinical Research Educational Modules, is a virtual wealth of information for anyone interested in #ClinicalResearch in challenging situations, or for project managers who want a taste of how their skills are needed around the world. These free modules can also count toward PDUs, CEUs, and CMEs. Intrigued? Learn more:

Celebrating 20 years of innovation at the Nanotechnology Characterization Laboratory (NCL) Symposium! ?? Last week, over 100 attendees joined us to mark two decades of groundbreaking contributions by the NCL to advancing cancer #nanotechnology. From streamlining nanotechnology’s path to clinical application to supporting researchers worldwide, the NCL continues to pave the way for safer, more effective cancer treatments. Attendees left inspired, equipped with fresh ideas, and new collaborative connections—all geared towards the next breakthroughs in nanomedicine. Here’s to more innovations in #CancerResearch.

November is National Lung Cancer Awareness Month. #DYK that a study by our Molecular Pharmacology Program team found that NSAIDs may boost lung cancer survival? “If survival benefits after NSAID use are confirmed in future randomized clinical trials, this could advance lung cancer practice,” noted the research team, led by FNL Director Ethan Dmitrovsky. Learn more ?? https://heyor.ca/5cfYSr

Are you coming to the next #BiotechConnector on November 21? Join us as we explore advances in next-generation sequencing. To learn about our speakers, visit ?? https://heyor.ca/IIjaCS

Did you know 1 in 5 people will be diagnosed with cancer in their lifetime? Breakthroughs in High-Performance Computing (HPC), #AI, #BigData, #PredictiveOncology, and #DigitalTwins are helping unlock new possibilities to improve lives and fight cancer more effectively. Whether you're in government, academia, or industry, this Birds of a Feather session is your chance to learn how HPC is driving groundbreaking research and clinical applications: https://heyor.ca/d0ludk #SC24

Are you going to be in Atlanta for this year's SC Conference Series? We're hosting the Computational Approaches for Cancer Workshop as part of #SC24 on Nov. 18. Check out our awesome agenda for #CAFCW24: https://heyor.ca/pR6uGi P.S. You can still register!

Our Molecular Characterization Laboratory is screening acute myeloid leukemia patients for NIH’s precision medicine clinical trial myeloMATCH, a successor to NCI-MATCH. Learn more ?? https://heyor.ca/AzwVhy National Cancer Institute (NCI)